A
Andrzej Rynkiewicz
Researcher at University of Warmia and Mazury in Olsztyn
Publications - 181
Citations - 18321
Andrzej Rynkiewicz is an academic researcher from University of Warmia and Mazury in Olsztyn. The author has contributed to research in topics: Coronary artery disease & Familial hypercholesterolemia. The author has an hindex of 23, co-authored 172 publications receiving 17380 citations. Previous affiliations of Andrzej Rynkiewicz include Gdańsk Medical University.
Papers
More filters
Journal ArticleDOI
[ESH/ESC 2007 Guidelines for the management of arterial hypertension]
Journal ArticleDOI
Inhibition of delta-protein kinase C by delcasertib as an adjunct to primary percutaneous coronary intervention for acute anterior ST-segment elevation myocardial infarction: results of the PROTECTION AMI Randomized Controlled Trial.
A. Michael Lincoff,Matthew T. Roe,Philip E. Aylward,John M. Galla,Andrzej Rynkiewicz,Victor Guetta,Michael Zelizko,Neal S. Kleiman,Harvey D. White,Ellen McErlean,David Erlinge,Mika Laine,Jorge Ferreira,Shaun G. Goodman,Shamir R. Mehta,Dan Atar,Harry Suryapranata,Svend Eggert Jensen,Tamás Forster,Antonio Fernández-Ortiz,Danny Schoors,Peter W. Radke,Guido Belli,Danielle M. Brennan,Gregory Bell,Mitchell W. Krucoff +25 more
TL;DR: Selective inhibition of delta-PKC with intravenous infusion of delcasertib during PCI for acute STEMI in a population of patients treated according to contemporary standard of care did not reduce biomarkers of myocardial injury.
Journal ArticleDOI
A Phase 2, randomized, partially blinded, active-controlled study assessing the efficacy and safety of variable anticoagulation reversal using the REG1 system in patients with acute coronary syndromes: results of the RADAR trial
Thomas J. Povsic,John P. Vavalle,Laura H. Aberle,Jarosław D. Kasprzak,Mauricio G. Cohen,Roxana Mehran,Christoph Bode,Christopher E. Buller,Gilles Montalescot,Jan H. Cornel,Andrzej Rynkiewicz,Michael E. Ring,Uwe Zeymer,Madhu K. Natarajan,Nicolas Delarche,Steven L. Zelenkofske,Richard C. Becker,John H. Alexander +17 more
TL;DR: REG1 appears a safe strategy to anticoagulate ACS patients managed invasively and warrants further investigation in adequately powered clinical trials of patients who require short-term high-intensity antICOagulation.
Journal ArticleDOI
Molecular characterization of Polish patients with familial hypercholesterolemia: novel and recurrent LDLR mutations.
M. Chmara,Bartosz Wasag,M. Zuk,Jolanta Kubalska,Agnieszka Węgrzyn,Małgorzata Bednarska-Makaruk,Ewa Pronicka,Hanna Wehr,J.C. Defesche,Andrzej Rynkiewicz,Janusz Limon +10 more
TL;DR: The findings imply that major rearrangements of theLDLR gene as well as 2 point mutations are frequent causes of ADH in Poland, and the heterogeneity ofLDLR mutations detected in the studied group confirms the requirement for complex molecular studies of Polish ADH patients.
Journal ArticleDOI
Sudden death in hypertrophic cardiomyopathy: old risk factors re-assessed in a new model of maximalized follow-up.
Pawel Petkow Dimitrow,Lidia Chojnowska,Tomasz Rudziński,Walerian Piotrowski,Lidia Ziółkowska,Andrzej Wojtarowicz,Anna Wycisk,Alicja Dąbrowska-Kugacka,Ewa Nowalany-Kozielska,Bożena Sobkowicz,Wojciech Wróbel,Janina Aleszewicz-Baranowska,Andrzej Rynkiewicz,Krystyna Łoboz-Grudzień,Michał Marchel,Andrzej Wysokiński +15 more
TL;DR: The proposed concept of a lifelong calculated follow-up is a useful strategy in the risk stratification of SD, predicting frequent SD episodes in the early period of life.